1 |
Maes ME, Wögenstein GM, Colombo G, Casado-Polanco R, Siegert S. Optimizing AAV2/6 microglial targeting identified enhanced efficiency in the photoreceptor degenerative environment. Mol Ther Methods Clin Dev 2021;23:210-24. [PMID: 34703843 DOI: 10.1016/j.omtm.2021.09.006] [Reference Citation Analysis]
|
2 |
Kalatzis V, Roux AF, Meunier I. Molecular Therapy for Choroideremia: Pre-clinical and Clinical Progress to Date. Mol Diagn Ther 2021. [PMID: 34661884 DOI: 10.1007/s40291-021-00558-y] [Reference Citation Analysis]
|
3 |
Zeng X, Li Z, Zhu C, Xu L, Sun Y, Han S. Research progress of nanocarriers for gene therapy targeting abnormal glucose and lipid metabolism in tumors. Drug Deliv 2021;28:2329-47. [PMID: 34730054 DOI: 10.1080/10717544.2021.1995081] [Reference Citation Analysis]
|
4 |
Sahu B, Chug I, Khanna H. The Ocular Gene Delivery Landscape. Biomolecules 2021;11:1135. [PMID: 34439800 DOI: 10.3390/biom11081135] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Ross M, Obolensky A, Averbukh E, Desrosiers M, Ezra-Elia R, Honig H, Yamin E, Rosov A, Dvir H, Gootwine E, Banin E, Dalkara D, Ofri R. Outer retinal transduction by AAV2-7m8 following intravitreal injection in a sheep model of CNGA3 achromatopsia. Gene Ther 2021. [PMID: 34853444 DOI: 10.1038/s41434-021-00306-1] [Reference Citation Analysis]
|